Patti, Francesco <br/><br/>
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis.  [electronic resource] 

 -  Expert opinion on drug metabolism & toxicology  Mar 2018 
 - 341-352 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7607 
<br/><br/><label>Standard No.: </label>10.1080/17425255.2018.1432594  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Biological Availability<br/>Daclizumab<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Immunosuppressive Agents--administration & dosage<br/>Interleukin-2 Receptor alpha Subunit--immunology<br/>Magnetic Resonance Imaging<br/>Medication Adherence<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy